First Time Loading...

MaxCyte Inc
LSE:MXCT

Watchlist Manager
MaxCyte Inc Logo
MaxCyte Inc
LSE:MXCT
Watchlist
Price: 297 GBX Market Closed
Updated: May 5, 2024
Section:
 

Relative Value

The Relative Value of one MXCT stock under the Base Case scenario is 342.67 GBX. Compared to the current market price of 297 GBX, MaxCyte Inc is Undervalued by 13%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MXCT Relative Value
Base Case
342.67 GBX
Undervaluation 13%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

9.4
P/S
P/S
Price to Sales
9.4
vs History
34
vs Industry
19
Median 3Y
10.9
Median 5Y
0
Industry
3.9
Forward
0.1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-26
Median 5Y
0
Industry
31.1
Forward
-0.1
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-40
Median 5Y
0
Industry
23.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-20.6
Median 5Y
0
Industry
27.4
More Details
1.7
P/B
P/B
Price to Book Value
1.7
vs History
49
vs Industry
61
Median 3Y
2.1
Median 5Y
1.7
Industry
2.5
More Details
Negative
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
Median 3Y
-538.9
Median 5Y
0
Industry
3.8
Forward
-4.7
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
-608.5
Median 5Y
0
Industry
7.9
More Details
372.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
372.6
vs History
34
vs Industry
1
Median 3Y
435.5
Median 5Y
0
Industry
17.2
Forward
3.9
More Details
340.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
340.4
vs History
34
vs Industry
1
Median 3Y
398.5
Median 5Y
0
Industry
22.7
Forward
2.9
More Details
758.2
EV/OCF
EV/OCF
Enterprise Value to OCF
758.2
vs History
30
vs Industry
0
Median 3Y
758.2
Median 5Y
0
Industry
21.4
More Details
647.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
647.7
vs History
25
vs Industry
0
Median 3Y
643.7
Median 5Y
0
Industry
27.9
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
Median 3Y
-411.3
Median 5Y
-911.9
Industry
2.4
More Details

Multiples Across Competitors

MXCT Competitors Multiples
MaxCyte Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
MaxCyte Inc
LSE:MXCT
308.8m GBP 9.4 -10.2 372.6 340.4
US
Thermo Fisher Scientific Inc
NYSE:TMO
221.3B USD 5.2 36.9 22.8 33.4
US
Danaher Corp
NYSE:DHR
184B USD 4.2 22.8 16.6 20.4
CH
Lonza Group AG
SIX:LONN
37.5B CHF 5.6 57.3 19.7 28.9
US
IQVIA Holdings Inc
NYSE:IQV
40.5B USD 2.7 29.9 16.3 25.2
US
Agilent Technologies Inc
NYSE:A
40.9B USD 6.1 33.1 26.4 31.8
KR
Samsung Biologics Co Ltd
KRX:207940
54.9T KRW 14.9 64 33.7 48.6
US
Mettler-Toledo International Inc
NYSE:MTD
26.9B USD 7.1 34.2 23.9 26.5
US
West Pharmaceutical Services Inc
NYSE:WST
26.6B USD 9.1 46.9 32.5 39.5
IE
ICON PLC
NASDAQ:ICLR
25.6B USD 3.1 37.4 16.9 26
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR 7.1 75.4 32.4 53.2

See Also

Summary
MXCT intrinsic value, competitors valuation, and company profile.
DCF Valuation
MXCT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MXCT stock valuation using valuation multiples.
Wall Street Estimates
MXCT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MXCT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.